Pathway,Score
Signaling by VEGF,0.07635541781070047
Negative regulation of the PI3K/AKT network,0.05745424288288018
PI3K/AKT Signaling in Cancer,0.01823260211154154
G beta:gamma signalling through PI3Kgamma,0.046282692516276314
G-protein beta:gamma signalling,-0.015013164352628764
VEGFA-VEGFR2 Pathway,0.01484347379821289
VEGFR2 mediated vascular permeability,0.002029343152194616
Constitutive Signaling by AKT1 E17K in Cancer,0.00039232470082911175
Respiratory Syncytial Virus Infection Pathway,0.013235606917664901
RSV-host interactions,0.0001480486518327683
RHO GTPases Activate WASPs and WAVEs,-0.011229147475234359
RAC2 GTPase cycle,0.0058296527054354915
RAC3 GTPase cycle,-0.01293912639062499
Parasite infection,0.023007019368350777
Leishmania phagocytosis,0.01681507921733723
FCGR3A-mediated phagocytosis,0.01724002846245143
Signaling by NOTCH1,-0.000464943857304687
NOTCH1 Intracellular Domain Regulates Transcription,-0.03510263351367037
Signaling by NOTCH1 PEST Domain Mutants in Cancer,0.032137410545182904
Signaling by NOTCH1 in Cancer,0.001122618646668507
Constitutive Signaling by NOTCH1 PEST Domain Mutants,-0.003163167576134393
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,-0.1520176629076538
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,-0.0004901789767519228
Regulation of PTEN gene transcription,0.04761273670511245
Budding and maturation of HIV virion,0.007907038251628206
Uptake and actions of bacterial toxins,0.007024299964292747
Bacterial Infection Pathways,-0.024540133094359807
NRAGE signals death through JNK,0.022474166016705384
p75 NTR receptor-mediated signalling,0.001052925514577153
"Cell death signalling via NRAGE, NRIF and NADE",0.031948346365226615
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,0.007813257688783153
Neurodegenerative Diseases,0.014399394776784764
Diseases of programmed cell death,0.01890596810984374
Defective Intrinsic Pathway for Apoptosis,-1.1184041819030428e-05
Signaling by SCF-KIT,-0.04311309651422727
Regulation of KIT signaling,0.030846621853342214
Degradation of beta-catenin by the destruction complex,0.012561571149620832
Beta-catenin phosphorylation cascade,0.004383622631120442
Disassembly of the destruction complex and recruitment of AXIN to the membrane,-0.0002167166939387723
G alpha (12/13) signalling events,0.014513369358533312
Pre-NOTCH Transcription and Translation,-0.06405835539729535
Pre-NOTCH Expression and Processing,-0.08918589342092019
Signaling by NOTCH2,-0.1518396524411074
NOTCH2 intracellular domain regulates transcription,-0.05363598597888455
Signaling by NOTCH3,0.013053611244204177
NOTCH3 Intracellular Domain Regulates Transcription,-0.03908821288739591
Signaling by NOTCH4,0.010689765298046282
NOTCH4 Intracellular Domain Regulates Transcription,3.352085894799556e-05
Signaling by MET,0.0473225973444216
RAS processing,0.013816387755755562
Potential therapeutics for SARS,0.006059669092586291
Host Interactions of HIV factors,-0.059409580481000916
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,-0.0006463057805332188
The role of Nef in HIV-1 replication and disease pathogenesis,0.03134715554592294
NR1H2 and NR1H3-mediated signaling,0.018843574276500585
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,0.040931244893614244
Diseases of glycosylation,0.05766105124960914
Diseases associated with O-glycosylation of proteins,0.024784322302259628
Defective GALNT3 causes HFTC,-0.0032882038408327515
Defective GALNT12 causes CRCS1,0.027571093747789342
Diseases of metabolism,0.005386209632338693
Diseases of DNA repair,0.029360509230520162
Diseases of DNA Double-Strand Break Repair,-0.03526094716117648
Defective homologous recombination repair (HRR) due to BRCA2 loss of function,-0.0272102298230219
Defective homologous recombination repair (HRR) due to BRCA1 loss of function,-0.0023428918996293855
Defective homologous recombination repair (HRR) due to PALB2 loss of function,-0.021522822268486275
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,0.0008030776408475615
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,0.0037809992426859037
Impaired BRCA2 binding to RAD51,0.0016987806866853876
Impaired BRCA2 binding to PALB2,0.08490446761569924
Effects of PIP2 hydrolysis,-0.061560681365553496
Integrin signaling,0.008090421963611847
Retrograde neurotrophin signalling,-0.006660964588861973
Signaling by NTRK1 (TRKA),-0.07505776160282551
TNFR1-induced proapoptotic signaling,0.00810019689903316
Regulation of TNFR1 signaling,-0.004139775262678956
TNFR1-induced NF-kappa-B signaling pathway,0.09019896407273426
TNF signaling,0.053509781755916926
RHOA GTPase cycle,0.013470950478412649
SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.011290334431075274
HCMV Infection,0.03684618067164932
HCMV Early Events,0.03372603923634279
Regulation of RAS by GAPs,-0.05104945072320501
RHOF GTPase cycle,-0.03816398775591111
P2Y receptors,-0.0020914512928268195
Nucleotide-like (purinergic) receptors,0.003980033552375105
Signaling by PTK6,-0.08643447366161895
Signaling by Non-Receptor Tyrosine Kinases,0.0036468819632147144
Signaling by Retinoic Acid,-0.010771998378179585
RA biosynthesis pathway,-0.03811649385750911
Signaling by ERBB2,0.005241065714277653
Downregulation of ERBB2 signaling,0.002063034071187538
Activated NOTCH1 Transmits Signal to the Nucleus,0.00029184144144707544
NOTCH2 Activation and Transmission of Signal to the Nucleus,0.0899542568070486
NOTCH3 Activation and Transmission of Signal to the Nucleus,0.014393564712968019
Opioid Signalling,-0.03370134415969348
DARPP-32 events,0.054655985224230035
Nuclear Events (kinase and transcription factor activation),-0.013676400372230543
Signaling by NTRK2 (TRKB),-0.0643374449909085
NGF-stimulated transcription,0.006107274543839707
Class B/2 (Secretin family receptors),0.06417576260406103
G alpha (s) signalling events,-0.006151885787725294
RHOB GTPase cycle,0.003589959423503116
RHOC GTPase cycle,-0.004130958876144636
Vpu mediated degradation of CD4,2.3725727723161134e-05
Vif-mediated degradation of APOBEC3G,-0.02544038440695517
PCP/CE pathway,-0.00025476809266070945
Asymmetric localization of PCP proteins,0.037523370417621035
Degradation of AXIN,0.016081458542411643
Degradation of DVL,0.000180116159619929
Hedgehog ligand biogenesis,-0.13424142971744518
Hh mutants are degraded by ERAD,0.0033114968384718633
Hh mutants abrogate ligand secretion,0.0018184208939218897
Degradation of GLI1 by the proteasome,-0.003999336036555087
Degradation of GLI2 by the proteasome,-0.20333430714516468
GLI3 is processed to GLI3R by the proteasome,-0.05722722328151616
Hedgehog 'off' state,-0.02515774325308343
ABC transporter disorders,0.010159552260456886
Disorders of transmembrane transporters,0.0280249668071521
Hedgehog 'on' state,0.053885385640046905
Defective CFTR causes cystic fibrosis,0.06453377981460916
MAPK6/MAPK4 signaling,0.011566379749445962
Regulation of PTEN stability and activity,-0.006071873357621809
Negative regulation of NOTCH4 signaling,-0.03214659625918546
Formation of HIV elongation complex in the absence of HIV Tat,-0.06274271061477174
Formation of the HIV-1 Early Elongation Complex,0.0035902675900858333
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,-0.042776740708635186
HIV Transcription Initiation,0.0002707855375967345
RNA Polymerase II HIV Promoter Escape,-0.0014717109877974168
HIV Transcription Elongation,-0.020784984838176552
Transcription of the HIV genome,0.00038416049521989047
Formation of HIV-1 elongation complex containing HIV-1 Tat,0.003347029548591528
Tat-mediated elongation of the HIV-1 transcript,-0.010201101387618927
RHOBTB3 ATPase cycle,0.0035513045589592937
Signaling by TGF-beta Receptor Complex,0.07313804022780813
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,-0.00564491503756769
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,-0.012836473194154891
Pausing and recovery of Tat-mediated HIV elongation,-0.010027730913042059
Tat-mediated HIV elongation arrest and recovery,-0.10304546259610625
HIV elongation arrest and recovery,0.0010163923772938486
Pausing and recovery of HIV elongation,-0.01663270046767871
Estrogen-dependent gene expression,0.015400338683265418
RHOBTB2 GTPase cycle,0.026425702454904092
RHOBTB1 GTPase cycle,0.05347692004602472
RHOBTB GTPase Cycle,-0.09208448762167636
Signaling by EGFR,0.03402824137397953
EGFR downregulation,-0.002930079628050013
Signaling by FGFR,0.07087743418922467
Negative regulation of FGFR1 signaling,0.010536077581734414
Negative regulation of FGFR2 signaling,0.014402413324753942
Negative regulation of FGFR3 signaling,-0.009517490519489729
Negative regulation of FGFR4 signaling,0.022500025574228564
Signaling by FGFR1,0.008543427795399683
Signaling by FGFR2,0.002839969825796093
Signaling by FGFR3,-0.0036545769845986557
Signaling by FGFR4,0.017176576541690573
Negative regulation of MET activity,-0.01905461811238668
InlB-mediated entry of Listeria monocytogenes into host cell,0.08162828459422508
Listeria monocytogenes entry into host cells,0.009761875090191696
RHOU GTPase cycle,0.004292709988072892
MAP2K and MAPK activation,0.030299147180313013
Signaling by moderate kinase activity BRAF mutants,0.023052149727382495
Signaling by high-kinase activity BRAF mutants,0.013092779721900722
Signaling by RAS mutants,-0.004270916138081518
Signaling by BRAF and RAF1 fusions,0.013062394623835589
Paradoxical activation of RAF signaling by kinase inactive BRAF,0.02532237362237879
Oncogenic MAPK signaling,0.0029590975886065354
Signaling downstream of RAS mutants,0.001654999949909452
Signaling by RAF1 mutants,0.01790598760890358
AKT phosphorylates targets in the cytosol,0.0005059085076997718
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,-0.04621845489024109
"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.0017082037245642172
Diseases of mitotic cell cycle,0.03604204986697481
FLT3 signaling in disease,-0.04765543957927478
Aberrant regulation of mitotic cell cycle due to RB1 defects,0.005016421707396763
Signaling by ALK in cancer,-0.039933544839262224
Signaling by FLT3 ITD and TKD mutants,-0.005145979574481675
Signaling by ALK fusions and activated point mutants,0.0007672979962524962
RHO GTPases activate CIT,0.04694267795169528
Extra-nuclear estrogen signaling,0.020287009120676176
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,0.0025236438854827513
Signaling by Activin,0.00013379627363643357
Downregulation of TGF-beta receptor signaling,-0.006989564459476094
TGF-beta receptor signaling activates SMADs,0.004341783895956371
G alpha (z) signalling events,-0.10233054049935644
Activation of RAC1,0.008884606129534591
RHOQ GTPase cycle,-0.016689312733084573
RHOH GTPase cycle,-0.11301295607867243
RHOG GTPase cycle,-0.026164968683673795
RHOJ GTPase cycle,0.12121137660773616
RHOV GTPase cycle,0.027710463039808418
Signaling by Insulin receptor,0.02548121274913327
Insulin receptor recycling,-0.000711877015671521
MET activates PTK2 signaling,0.008893717033032055
MET promotes cell motility,-0.14322983982737916
MTOR signalling,0.00800553232425436
mTORC1-mediated signalling,0.0015362393676287122
Energy dependent regulation of mTOR by LKB1-AMPK,0.028493484463815635
Diseases of Immune System,0.025534300103311498
Diseases associated with the TLR signaling cascade,-0.004245869564143562
RHO GTPases activate IQGAPs,0.0004921269729928642
RHO GTPases Activate Formins,0.04281940478146697
RHO GTPases activate PKNs,-0.009950516589035409
RHO GTPases Activate ROCKs,-0.03446377912471151
RHO GTPases activate PAKs,-0.09712767902904536
Aberrant regulation of mitotic exit in cancer due to RB1 defects,0.0027123866702977407
Pre-NOTCH Processing in Golgi,0.013417926850999242
Signaling by ERBB4,-0.002537255273295625
Nuclear signaling by ERBB4,0.016103914374852094
Signaling by Hippo,0.02074696978281325
RHOD GTPase cycle,-0.00894831390636043
SARS-CoV-1-host interactions,-0.19951056198149011
SARS-CoV-1 activates/modulates innate immune responses,-0.005506578708657618
RND3 GTPase cycle,0.023526415001263765
Nuclear events stimulated by ALK signaling in cancer,0.006859283833756081
HCMV Late Events,-0.03766341879358591
Formation of the beta-catenin:TCF transactivating complex,0.01707506639982758
Peptide ligand-binding receptors,-0.010232569251622508
Chemokine receptors bind chemokines,-6.934162569923163e-05
Translation of Structural Proteins,0.012439149244212525
Maturation of spike protein,0.009889085203006905
Late SARS-CoV-2 Infection Events,-0.30508685878323966
Purinergic signaling in leishmaniasis infection,-0.007403917790779881
Cell recruitment (pro-inflammatory response),0.00939444998845672
CaMK IV-mediated phosphorylation of CREB,-0.00836966191141276
Calmodulin induced events,-0.00317385759248614
Ca-dependent events,0.025641185834250603
CaM pathway,-0.01856433823514908
G-protein mediated events,0.023176905727295603
PLC beta mediated events,-0.05054498086340761
DAG and IP3 signaling,0.02824378900566583
G-protein activation,0.002473679810588412
Ca2+ pathway,-0.009784759092973633
G beta:gamma signalling through PLC beta,0.0001903268429538687
Glucagon-type ligand receptors,0.0006970285596678005
G beta:gamma signalling through BTK,-0.006538143272771634
G beta:gamma signalling through CDC42,-0.04101973713640215
GPER1 signaling,0.004352608635114757
ADORA2B mediated anti-inflammatory cytokines production,-0.007670792447692003
Anti-inflammatory response favouring Leishmania parasite infection,0.0018226463735680275
Leishmania parasite growth and survival,0.0019750027235305246
PKA-mediated phosphorylation of CREB,-0.019828995698431186
PKA activation,0.007663864351991296
Adenylate cyclase activating pathway,-0.006296328118841605
Adenylate cyclase inhibitory pathway,-0.004065310402989423
FCGR3A-mediated IL10 synthesis,0.0005339781477144824
Signaling by ERBB2 in Cancer,0.009669639040081406
Constitutive Signaling by Aberrant PI3K in Cancer,0.0071499348176129705
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",-0.16582825504469384
Signaling by ERBB2 KD Mutants,-0.0018057069709341003
Signaling by ERBB2 TMD/JMD mutants,0.01013234178961596
RND2 GTPase cycle,0.03447370811391759
Signaling by TGFBR3,-0.0009162306563781249
Rev-mediated nuclear export of HIV RNA,0.0011003835002467266
Transport of Ribonucleoproteins into the Host Nucleus,0.006028646304041478
Export of Viral Ribonucleoproteins from Nucleus,0.00069823010632515
NS1 Mediated Effects on Host Pathways,-4.019580199204286e-05
Viral Messenger RNA Synthesis,0.04078114692191354
NEP/NS2 Interacts with the Cellular Export Machinery,0.009343498213781956
Interactions of Vpr with host cellular proteins,0.030308312691822343
Interactions of Rev with host cellular proteins,0.005734440068010282
Nuclear import of Rev protein,-0.10099942887946442
Vpr-mediated nuclear import of PICs,0.0023177254105807656
SLC transporter disorders,-0.02091736234074588
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),0.005411619447137428
VEGFR2 mediated cell proliferation,-0.003945989268031745
Eicosanoid ligand-binding receptors,-0.028510897921066227
RHO GTPases Activate NADPH Oxidases,0.03787137030958627
Downstream signaling of activated FGFR1,-0.0020345504285962995
FRS-mediated FGFR1 signaling,0.0029350872695784198
Downstream signaling of activated FGFR2,0.006598554084714917
FRS-mediated FGFR2 signaling,0.008511751569665483
FRS-mediated FGFR3 signaling,0.0014973568285117278
Downstream signaling of activated FGFR3,-0.04084420234794111
FRS-mediated FGFR4 signaling,0.00907466431281395
Downstream signaling of activated FGFR4,-0.00747775172791234
RND1 GTPase cycle,-0.04762625047289967
Signaling by FGFR in disease,0.029453192837366013
Prolonged ERK activation events,-0.003653952434143239
Frs2-mediated activation,-0.0005891016366999125
Signalling to ERKs,-0.030401046952645856
Signaling by ALK,-0.012795892105872179
Signaling by FGFR2 in disease,-0.04869234245729416
Signaling by FGFR1 in disease,-0.03896491806356201
Signaling by FGFR3 in disease,0.002574311332084444
SARS-CoV-1 targets host intracellular signalling and regulatory pathways,0.005628366684779016
Activation of SMO,-0.007974446297921434
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,0.005728348706564736
Signaling by EGFR in Cancer,0.01614222385029386
Constitutive Signaling by EGFRvIII,-0.019553227256943955
Signaling by EGFRvIII in Cancer,0.003916966457331254
Signaling by Ligand-Responsive EGFR Variants in Cancer,0.02216855995511825
Signaling by ERBB2 ECD mutants,0.012443759446882308
Infection with Mycobacterium tuberculosis,0.021548366610052525
Response of Mtb to phagocytosis,-0.014106611155904308
Signaling by BMP,-0.03808459241154518
Early Phase of HIV Life Cycle,-0.014370289488806516
SARS-CoV-2 modulates host translation machinery,-0.010740396415365415
RAF-independent MAPK1/3 activation,0.0003497665371989845
Negative regulation of MAPK pathway,0.0026484949726981125
Viral mRNA Translation,0.009688584695465907
Amine ligand-binding receptors,-0.006112967194352301
Neurotoxicity of clostridium toxins,0.0025850882911312447
SARS-CoV-2 modulates autophagy,-0.01504093780285804
PI3K Cascade,-0.05823976492235952
IRS-mediated signalling,-0.030828675687692094
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),0.004317485412203109
IGF1R signaling cascade,-0.03011329767958199
IRS-related events triggered by IGF1R,0.011858178715585683
Insulin receptor signalling cascade,-0.008524391225350402
WNT5A-dependent internalization of FZD4,-0.0004531396197573979
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",-0.0257189290505242
Induction of Cell-Cell Fusion,-0.1078587991581805
Signaling by PDGF,0.00885057253102834
Translation of Replicase and Assembly of the Replication Transcription Complex,0.010838835816953322
Early SARS-CoV-2 Infection Events,0.02760957912480409
Assembly Of The HIV Virion,-0.009296998101789168
Evasion by RSV of host interferon responses,0.011420345505509794
Downstream signal transduction,0.010206430649606758
p130Cas linkage to MAPK signaling for integrins,-0.016183576855878363
Signaling by Erythropoietin,0.01652418076867537
SARS-CoV-1 modulates host translation machinery,0.00326914295995624
Downregulation of SMAD2/3:SMAD4 transcriptional activity,-1.875852828799903e-05
Maturation of nucleoprotein,-0.0008023775245049935
Signalling to RAS,0.023093719427782013
FGFR2 ligand binding and activation,0.00019499405434747605
Signaling by WNT in cancer,-0.05024861458725608
Signaling by AXIN mutants,0.04327277573259628
Signaling by CTNNB1 phospho-site mutants,-0.015720454818124386
Signaling by APC mutants,0.0263817548930247
Signaling by AMER1 mutants,0.026802583068824295
Signaling by GSK3beta mutants,0.0006478944689354926
CTNNB1 S33 mutants aren't phosphorylated,-0.01444508080714464
CTNNB1 S37 mutants aren't phosphorylated,0.011676348931027881
CTNNB1 S45 mutants aren't phosphorylated,0.012247878763983868
CTNNB1 T41 mutants aren't phosphorylated,0.0032183020679412947
APC truncation mutants have impaired AXIN binding,-0.11659700791074423
AXIN missense mutants destabilize the destruction complex,-0.019736162501589695
Truncations of AMER1 destabilize the destruction complex,-0.03102521588157802
"Respiratory syncytial virus (RSV) genome replication, transcription and translation",0.05075710142707577
Maturation of hRSV A proteins,-0.04600793289658276
RHO GTPases activate KTN1,-0.0017630012295857475
Deactivation of the beta-catenin transactivating complex,0.06405962010061102
Repression of WNT target genes,0.001696467528889923
FGFR4 ligand binding and activation,-0.0034838117170561383
Phospholipase C-mediated cascade; FGFR4,0.0069032540018087755
SHC-mediated cascade:FGFR4,0.021817508188433834
PI-3K cascade:FGFR4,0.03931758104894511
STAT3 nuclear events downstream of ALK signaling,0.0005507361200629467
Defective pyroptosis,-0.028537391705554662
ERK/MAPK targets,-0.03133464062598327
ERKs are inactivated,0.024798255066558215
TGFBR3 expression,-0.0157911675493706
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),0.0031089745916953195
Class C/3 (Metabotropic glutamate/pheromone receptors),0.01914832048395975
FGFR1 mutant receptor activation,-0.011194417456106111
FGFR2 mutant receptor activation,0.01289490415527149
Activated point mutants of FGFR2,0.024257285387433776
Phospholipase C-mediated cascade; FGFR2,-0.0007642223494522035
PI-3K cascade:FGFR1,-0.01978838072438335
PI-3K cascade:FGFR2,-0.023266084115720776
SHC-mediated cascade:FGFR2,0.0006054402873756382
Signaling by FGFR2 IIIa TM,0.00520748526546499
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),-0.008445326719607607
Abortive elongation of HIV-1 transcript in the absence of Tat,0.01468558115297779
FGFR2 alternative splicing,0.004468315146908073
Regulation of PTEN mRNA translation,0.026310695605561554
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,0.009846000528568813
NRIF signals cell death from the nucleus,-0.0029445143005930453
Signaling by KIT in disease,-0.0809115530572313
"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",-0.0052820159132655874
Loss of function of MECP2 in Rett syndrome,0.00023036996729588048
Pervasive developmental disorders,-0.0003379713193926757
Disorders of Developmental Biology,0.04444658839007459
Disorders of Nervous System Development,0.024132250560367417
Defects in vitamin and cofactor metabolism,-0.0013821481137440527
Regulation of FZD by ubiquitination,0.00017334250048626823
Serotonin receptors,0.00713647794181415
p75NTR signals via NF-kB,0.025783588832199306
Signaling by NTRK3 (TRKC),5.104163237374655e-05
RAF activation,-0.018839945111567336
p75NTR regulates axonogenesis,-0.0009503817248268706
WNT ligand biogenesis and trafficking,0.0020457624972245844
